CLOSE X
GO

Nippon India Pharma Fund(G)

very highequitypharma & health care
504.69 1.59(0.32%) NAV as on 17 Apr 2026
0.91 % 1 M
3.57 % 1 Y
21.92 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.82

As on 31 Mar, 2026
age-icon Age :

21 yrs 10 m

Since 05 06 ,2004
exit_load Exit Load :

1%

aum AUM :

7,898.24 Crs

lock_in Lock-in :

1% on or before 1M, Nil after 1M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.04

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Sailesh Raj Bhan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2026
Others 0.54 %
Equity 99.46 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.92 %
Lupin Ltd.8.45 %
Divi's Laboratories Ltd.6.41 %
Dr. Reddy's Laboratories Ltd.5.96 %
Cipla Ltd.5.42 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs75.25
Hospital & Healthcare Services19.42
Retailing3.86
Business Support0.93
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)290.14270.59428.87481.27489.71
Net Assets(Rs Crores) (as on 31-Mar-2026) 4931.89 4304.46 7125.28 8080.97 7898.24
Scheme Returns(%)(Absolute)14.83-6.8558.2410.943.30
B'mark Returns(%)(Absolute)NANANANANA
Category Rank43/7565/7617/9030/10225/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Pharma Fund(G)Very HighEquity504.691.59(0.32%)NAV As on 17 Apr, 202605-Jun-2004Inception Date7,898.24AUM In Cr.3.57%1Y21.92%3Y13.45%5Y19.63%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity38.760.27(0.70%)NAV As on 17 Apr, 202613-Jul-2018Inception Date6,293.14AUM In Cr.6.10%1Y26.51%3Y15.90%5Y19.06%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity430.582.76(0.64%)NAV As on 17 Apr, 202614-Jul-1999Inception Date4,063.64AUM In Cr.4.19%1Y24.41%3Y15.77%5Y15.79%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity30.970.15(0.49%)NAV As on 17 Apr, 202610-Jul-2019Inception Date858.87AUM In Cr.4.56%1Y22.69%3Y12.42%5Y18.16%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors